Autopsy report · NCT02721875
Trial of Volasertib With or Without Azacitidine in Patients With Myelodysplastic Syndromes
Cause of deathNo reason given
Life of this trial
- Registered 1 month before it started.
- Ran for about 3 months before it stopped.
- 1 participant enrolled.
- Results were posted on the registry 2 years after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- Boehringer Ingelheim
- Sponsor type
- Industry
- Conditions
- Myelodysplastic Syndromes
- Interventions
- Volasertib; Volasertib; Azacitidine
- Participants
- 1
- Sites
- 1
- Countries
- Japan
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.